aTyr Pharma Announces Third Quarter 2018 Operating Results and Provides Corporate Update

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 7/7/2026

1. MU
2. SPY
3. SPCX
4. APTX:CN
5. IQMX
6. EROC
7. MSTR
8. RIVN
9. TSLA
10. MSFT

Go back to aTyr Pharma Announces Third Quarter 2018 Operating Results and Provides Corporate Update

aTyr Pharma (LIFE) Reports Q3 Loss of $0.24

November 13, 2018 4:21 PM EST

aTyr Pharma (NASDAQ: LIFE) reported Q3 EPS of ($0.24).

We continue to advance the development of our lead product candidate, ATYR1923, and have selected pulmonary sarcoidosis as the indication for our upcoming proof-of-concept clinical study, said Sanjay Shukla, M.D., M.S., President... More